Nexgen Arrays Overview
- Founded
-
2013

- Status
-
Private
- Employees
-
5

- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$374K
- Investors
-
3
Nexgen Arrays General Information
Description
Developer of diagnostic technology designed for detecting Ebola viruses. The company's platform specializes in a molecular diagnostic, enabling medical specialists to detect viral diseases such as Ebola, Lassa, and Marburg.
Contact Information
Website
nvdx-platform.launchrock.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Primary Office
- 8 Saint Mary's Street
- Boston, MA 02215
- United States
+1 (617) 000-0000
Nexgen Arrays Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Grant | 01-Jan-2015 | $374K | Completed | Startup | ||
2. Grant | 30-Sep-2014 | 0000 | Completed | Startup | ||
1. Accelerator/Incubator | 01-Jan-2014 | Completed | Startup |
Nexgen Arrays Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
George Daaboul Ph.D | Co-Founder & Chief Scientific Officer |
Nexgen Arrays Signals
Nexgen Arrays Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
National Science Foundation | Government | 000 0000 | 000000 0 | ||
MassChallenge | Accelerator/Incubator | 000 0000 | 000000 0 |